SouthState Corp’s Bionano Genomics BNGO Stock Holding History

SouthState Corp’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$136	–	602
2023 Q3	$136	Buy	+1	New	+$262	﹤0.01%	624

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SouthState Corp's BNGO Position: Q4 2023 in Review

SouthState Corp sold out of Bionano Genomics (BNGO) in Q4 2023, closing a stake of 1 share — an estimated $136 sold.

SouthState Corp first reported a position in BNGO in Q3 2023 and held it in 1 quarter. The position peaked at $136 in Q3 2023. 62 funds tracked by Wall St. Rank hold BNGO as of Q4 2023.

SouthState Corp reported no remaining Bionano Genomics position as of Q4 2023 after selling out during the quarter.
SouthState Corp sold 1 Bionano Genomics share in Q4 2023, an estimated $136.
SouthState Corp first reported a position in Bionano Genomics in Q3 2023 and held it in 1 quarter.
SouthState Corp's Bionano Genomics position peaked at $136 in Q3 2023.
62 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2023.

Based on SouthState Corp's 13F filing for Q4 2023, filed 6 Feb 2024.